×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
RVMD – revolution medicines, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
RVMD
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/2
08:09 am
rvmd
Revolution Medicines Begins Treating Patients in Phase 3 RASolute 303 Trial Evaluating Daraxonrasib as First Line Treatment for Patients with Metastatic Pancreatic Cancer [Yahoo! Finance]
Medium
Report
Revolution Medicines Begins Treating Patients in Phase 3 RASolute 303 Trial Evaluating Daraxonrasib as First Line Treatment for Patients with Metastatic Pancreatic Cancer [Yahoo! Finance]
4/2
08:00 am
rvmd
Revolution Medicines Begins Treating Patients in Phase 3 RASolute 303 Trial Evaluating Daraxonrasib as First Line Treatment for Patients with Metastatic Pancreatic Cancer
Medium
Report
Revolution Medicines Begins Treating Patients in Phase 3 RASolute 303 Trial Evaluating Daraxonrasib as First Line Treatment for Patients with Metastatic Pancreatic Cancer
4/1
01:27 pm
rvmd
A Look At Revolution Medicines (RVMD) Valuation After Recent Share Price Momentum [Yahoo! Finance]
Low
Report
A Look At Revolution Medicines (RVMD) Valuation After Recent Share Price Momentum [Yahoo! Finance]
3/30
07:57 am
rvmd
Jefferies Highlights Revolution Medicines, Inc. (RVMD)'s RAS(ON) Platform in Coverage Initiation [Yahoo! Finance]
Low
Report
Jefferies Highlights Revolution Medicines, Inc. (RVMD)'s RAS(ON) Platform in Coverage Initiation [Yahoo! Finance]
3/29
07:23 pm
rvmd
Is Revolution Medicines, Inc. (RVMD) A Good Stock To Buy Now? [Yahoo! Finance]
Low
Report
Is Revolution Medicines, Inc. (RVMD) A Good Stock To Buy Now? [Yahoo! Finance]
3/27
08:05 pm
rvmd
Revolution Medicines (RVMD) Down 8.8% Since Last Earnings Report: Can It Rebound? [Yahoo! Finance]
Low
Report
Revolution Medicines (RVMD) Down 8.8% Since Last Earnings Report: Can It Rebound? [Yahoo! Finance]
3/26
05:49 am
rvmd
Revolution Medicines (RVMD) was upgraded by Truist Financial Corporation to "strong-buy".
Low
Report
Revolution Medicines (RVMD) was upgraded by Truist Financial Corporation to "strong-buy".
3/19
02:44 pm
rvmd
Revolution, Ascendis, Arrowhead among RBC's top M&A candidates in biotech [Seeking Alpha]
Low
Report
Revolution, Ascendis, Arrowhead among RBC's top M&A candidates in biotech [Seeking Alpha]
Date
Time
Symbol
Company Name
Action
%Chg
2/25/2026
04:02 pm
rvmd
revolution medicines, inc.
MISS
Report
-1.1%
revolution medicines, inc.
11/5/2025
04:02 pm
rvmd
revolution medicines, inc.
MISS
Report
3.4%
revolution medicines, inc.
8/6/2025
04:02 pm
rvmd
revolution medicines, inc.
MISS
Report
-4.7%
revolution medicines, inc.
5/7/2025
04:02 pm
rvmd
revolution medicines, inc.
MISS
Report
11.3%
revolution medicines, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/27
11:38 am
rvmd
Form SCHEDULE 13G/A Revolution Medicines, Filed by: VANGUARD GROUP INC
Low
Report
Form SCHEDULE 13G/A Revolution Medicines, Filed by: VANGUARD GROUP INC
3/26
08:04 pm
rvmd
Form 4 Revolution Medicines, For: Mar 25 Filed by: Mancini Anthony
Low
Report
Form 4 Revolution Medicines, For: Mar 25 Filed by: Mancini Anthony
3/26
08:02 pm
rvmd
Form 144 Revolution Medicines, Filed by: Mancini Anthony
Low
Report
Form 144 Revolution Medicines, Filed by: Mancini Anthony
3/26
06:44 pm
rvmd
Form 3 Revolution Medicines, For: Mar 20 Filed by: Mancini Anthony
Low
Report
Form 3 Revolution Medicines, For: Mar 20 Filed by: Mancini Anthony
3/26
06:35 pm
rvmd
Form 3 Revolution Medicines, For: Mar 20 Filed by: Sandler Alan B.
Low
Report
Form 3 Revolution Medicines, For: Mar 20 Filed by: Sandler Alan B.
3/19
06:58 pm
rvmd
Form 4 Revolution Medicines, For: Mar 17 Filed by: Wei Lin
Medium
Report
Form 4 Revolution Medicines, For: Mar 17 Filed by: Wei Lin
3/19
06:57 pm
rvmd
Form 4 Revolution Medicines, For: Mar 17 Filed by: Kelsey Stephen Michael
Medium
Report
Form 4 Revolution Medicines, For: Mar 17 Filed by: Kelsey Stephen Michael
3/19
06:57 pm
rvmd
Form 4 Revolution Medicines, For: Mar 17 Filed by: GOLDSMITH MARK A
Medium
Report
Form 4 Revolution Medicines, For: Mar 17 Filed by: GOLDSMITH MARK A
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
4/29
Revolution Medicines Announces Publication of Scientific Paper Describing Anti-Tumor Immunity Induced by SHP2 Inhibitor in Preclinical Cancer Models
8.7%
3/18 Form SEC STAFF LETTER Revolution Medicines, 7.6%
4/16 Bill.com Holdings (NASDAQ: RVMD) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $27.00 price target on the stock. 6.6%
2/24 Form SC 13G Revolution Medicines, Filed by: Cormorant Asset Management, LP 4.5%
2/14 Form 4 Revolution Medicines, For: Feb 12 Filed by: Kelsey Stephen Michael 3.8%
2/18 Revolution Medicines Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares 3.3%
3/20 Form 8-K Revolution Medicines, For: Mar 18 3.1%
4/21 Form 8-K Revolution Medicines, For: Apr 17 2.6%
2/12 Form 3 Revolution Medicines, For: Feb 12 Filed by: GOEDDEL DAVID V 2.4%
4/17 Bill.com Holdings (NASDAQ: RVMD) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 1.7%
3/18 Form SEC STAFF LETTER Revolution Medicines, 7.6%
4/16 Bill.com Holdings (NASDAQ: RVMD) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $27.00 price target on the stock. 6.6%
2/24 Form SC 13G Revolution Medicines, Filed by: Cormorant Asset Management, LP 4.5%
2/14 Form 4 Revolution Medicines, For: Feb 12 Filed by: Kelsey Stephen Michael 3.8%
2/18 Revolution Medicines Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares 3.3%
3/20 Form 8-K Revolution Medicines, For: Mar 18 3.1%
4/21 Form 8-K Revolution Medicines, For: Apr 17 2.6%
2/12 Form 3 Revolution Medicines, For: Feb 12 Filed by: GOEDDEL DAVID V 2.4%
4/17 Bill.com Holdings (NASDAQ: RVMD) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 1.7%
TOP News Decliners
3/12
Form SEC STAFF LETTER Revolution Medicines,
-17.9%
5/1 Bill.com Holdings (NASDAQ: RVMD) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $38.00 price target on the stock. -5.7%
2/20 Form 4 Revolution Medicines, For: Feb 18 Filed by: Exter Neil -3.9%
2/14 Form SC 13G/A Revolution Medicines, Filed by: Boxer Capital, LLC -2.3%
3/30 Form 10-K Revolution Medicines, For: Dec 31 -1.9%
3/18 Revolution Medicines Announces Issuance of U.S. Patent Covering Compositions of Matter for its Clinical-Stage SHP2 Inhibitor Program -1.6%
2/19 Revolution Medicines Joins Amgen and Mirati in Quest for New Type of Cancer Drugs [Yahoo! Finance News] -0.9%
3/9 New Clinical Trial Exploring Revolution Medicines’ Investigational SHP2 Inhibitor RMC-4630 in Combination with an ERK Inhibitor Announced by Netherlands Cancer Institute -0.4%
2/13 Form SC 13G Revolution Medicines, Filed by: Boxer Capital, LLC -0.3%
5/1 Bill.com Holdings (NASDAQ: RVMD) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $38.00 price target on the stock. -5.7%
2/20 Form 4 Revolution Medicines, For: Feb 18 Filed by: Exter Neil -3.9%
2/14 Form SC 13G/A Revolution Medicines, Filed by: Boxer Capital, LLC -2.3%
3/30 Form 10-K Revolution Medicines, For: Dec 31 -1.9%
3/18 Revolution Medicines Announces Issuance of U.S. Patent Covering Compositions of Matter for its Clinical-Stage SHP2 Inhibitor Program -1.6%
2/19 Revolution Medicines Joins Amgen and Mirati in Quest for New Type of Cancer Drugs [Yahoo! Finance News] -0.9%
3/9 New Clinical Trial Exploring Revolution Medicines’ Investigational SHP2 Inhibitor RMC-4630 in Combination with an ERK Inhibitor Announced by Netherlands Cancer Institute -0.4%
2/13 Form SC 13G Revolution Medicines, Filed by: Boxer Capital, LLC -0.3%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: